Style | Citing Format |
---|---|
MLA | Shafiee F, et al.. "In-Vivo Evaluation of Dt386-Br2, a Promising Anticancer Fusion Protein, in Mice Model." Journal of Isfahan Medical School, vol. 35, no. 433, 2017, pp. 655-661. |
APA | Shafiee F, Enteshari R, Rabbani M, Jahaniannajafabadi A (2017). In-Vivo Evaluation of Dt386-Br2, a Promising Anticancer Fusion Protein, in Mice Model. Journal of Isfahan Medical School, 35(433), 655-661. |
Chicago | Shafiee F, Enteshari R, Rabbani M, Jahaniannajafabadi A. "In-Vivo Evaluation of Dt386-Br2, a Promising Anticancer Fusion Protein, in Mice Model." Journal of Isfahan Medical School 35, no. 433 (2017): 655-661. |
Harvard | Shafiee F et al. (2017) 'In-Vivo Evaluation of Dt386-Br2, a Promising Anticancer Fusion Protein, in Mice Model', Journal of Isfahan Medical School, 35(433), pp. 655-661. |
Vancouver | Shafiee F, Enteshari R, Rabbani M, Jahaniannajafabadi A. In-Vivo Evaluation of Dt386-Br2, a Promising Anticancer Fusion Protein, in Mice Model. Journal of Isfahan Medical School. 2017;35(433):655-661. |
BibTex | @article{ author = {Shafiee F and Enteshari R and Rabbani M and Jahaniannajafabadi A}, title = {In-Vivo Evaluation of Dt386-Br2, a Promising Anticancer Fusion Protein, in Mice Model}, journal = {Journal of Isfahan Medical School}, volume = {35}, number = {433}, pages = {655-661}, year = {2017} } |
RIS | TY - JOUR AU - Shafiee F AU - Enteshari R AU - Rabbani M AU - Jahaniannajafabadi A TI - In-Vivo Evaluation of Dt386-Br2, a Promising Anticancer Fusion Protein, in Mice Model JO - Journal of Isfahan Medical School VL - 35 IS - 433 SP - 655 EP - 661 PY - 2017 ER - |